Vera Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Vera Therapeutics, Inc. (VERA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.090.050.040.080.05
Short-Term Investments0.550.120.070.000.00
Cash & Short-Term Investments0.640.160.110.080.05
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.000.010.010.000.00
Total Current Assets0.650.170.130.080.05
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.010.000.00
Long-Term Investments0.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.000.000.010.000.00
Total Assets0.660.180.130.080.05
Current Liabilities
Accounts Payable0.010.010.010.000.00
Short-Term Debt0.000.000.000.000.00
Accrued Liabilities0.020.010.010.010.00
Other Current Liabilities0.020.000.000.000.00
Total Current Liabilities0.030.020.030.010.00
Non-Current Liabilities
Long-Term Debt0.050.050.020.000.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.050.050.030.010.00
Total Liabilities0.080.070.050.010.00
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-0.46-0.31-0.21-0.12-0.09
Accumulated Other Comprehensive Income0.000.000.000.000.00
Additional Paid-in Capital1.040.410.290.190.00
Shares Outstanding0.060.040.030.020.00
Total Stockholders' Equity0.580.100.080.070.05
Total Liabilities & Equity0.660.180.130.080.00